Custom Silica: Tailoring Particle Size, Surface Treatment and Purity to Your Application

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Wollastonite vs Silica: Filler Performance and Applications Compared
  • Keywords: pharmaceutical grade silica
  • Published: 2026-11-20 01:15:34
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Silicon Dioxide in Food: Why It Is Added and Whether It Is Safe

What Is Silica D50? How Median Particle Size Is Measured and Why It Matters
Silica Powder Supplier Guide: How to Compare Grades, Quality and Pricing
The size of the particles greatly affects the interaction with epithelial cells, cellular absorption, and therefore their effectiveness [ 1, 10, 12 ]. Furthermore, the size also influences the leakage of the API [ 12 ]. It has been proven in vitro that epithelial permeability can be increased by decreasing the size [ 1, 12, 13, 24 ]. Zhang et al. also observed that the cellular uptake of MSNs occurred in a time-, concentration-, and size-dependent manner based on in vitro studies performed on Caco-2 cell lines (20 nm, 60 nm, 90 nm) [ 24 ]. Nevertheless, more complex findings were gained in vivo. Wang et al. compared differently sized nanoparticles in various elements (100 nm, 250 nm, 480 nm) [ 12 ]. Similarly, Lamson et al. compared MSNs with different sizes to observe the influence of the particle size on bioavailability (20-1200 nm) [ 13 ]. Larger particles (normally around 500 nm) show slower release of the API and can form a strong interaction with the cell membrane [ 12 ], but cellular uptake is limited owing to their large size [ 1, 12 ]. Smaller particles (below 100 nm) show weaker interaction with the cell membrane but exert superb cellular uptake owing to their small size [ 12 ]. On the other hand, the smaller particles can slowly diffuse through the mucin layer covering the surface of the intestinal mucosa, become trapped in it, and aggregate, further worsening the absorption [ 1, 12, 13 ]. Furthermore, the decreasing particle size leads to increased release rate, owing to the larger specific surface area and faster degradation of the particles [ 1, 12 ], which can lead to early leakage of the molecules, worsening their absorption [ 1, 12 ]. As the diameter increases, the rate of degradation and drug release kinetics decreases, so larger particles have a longer half-life [ 12 ].
What Is Spherical Silica? Benefits, Specifications and Uses in Semiconductor Packaging
Silicon Dioxide Side Effects: What You Need to Know

Silica as a Rheology Modifier: How It Controls Viscosity and Flow

What is silica (SiO₂)?

silica manufacturers list

What is the difference between fumed silica and precipitated silica?

HDK N20 Even though MSNs can usually be recognized as secure products, their use during therapy may cause side impacts in the body [ 1, 2, 29 ]. Due to their small size and large surface area, they may tend to accumulate in the body, or certain organs (liver, spleen, kidney, lung) and may even be toxic in higher concentrations, which is a clear disadvantage [ 1, 4, 27 ]. The silanol groups (Si-OH) on their surface can interact with the phospholipid layer of the cell membrane, thereby causing cell lysis or, in extreme cases, hemolysis [ 4, 8 ]. In severe cases, the lack of hemocompatibility can also cause issues [ 2 ]. Overall, indications of cytotoxicity, haemotoxicity, and genotoxicity were also found [ 4, 8 ]. That is why the biocompatibility of all comparable preparations must be strictly controlled [ 2, 4, 27 ]. The physicochemical features (particle size, particle morphology, surface chemistry, pore structure, etc.) of nanocarriers also have a major impact on toxicity [ 2, 4, 8, 30 ]. Additionally, further attention must be paid to the biological influences of their decomposition products, because they may also cause unwanted side influences [ 1 ]. The breakdown of silica nanoparticles in the body can take up to a few days. The opening hydration is followed by hydrolysis, and, in the end, they are excreted in the urine in the form of silicic acid [ 1 ]. Nevertheless, the literature is contradictory in this regard [ 31 ]. Some experiments show no considerable cytotoxic effect [ 18, 31 ], while other experiments say otherwise [ 23, 32 ]. For example, an in vitro study was performed with multiple concentrations, surfaces, and particle sizes (60 nm, 100 nm, 300 nm) of MSNs, with an exposure time of 72 h [ 18 ]. This study shown no significant cytotoxic influence in any of the cell lines tested (human cervical (HeLA), epithelial lung (A549), and glioblastoma (U251)) [ 18 ]. Ismail et al. investigated the cytotoxic effect of silica nanoparticles in vivo in mouse models [ 33 ]. Amorphous silica nanoparticles were administered to the animals orally, at a dose of 150 mg/kg/day, for 3 months. Based on these mouse models, no toxic effects were detected under sub-chronic treatment of the nanoparticles [ 31 ]. In another study, particle size (15 nm, 60 nm, 200 nm) dependent impact was observed on cellular viability in all four cell lines tested (THP-1 derived macrophages, A549 epithelial cells, HaCaT keratinocytes, and NRK-52E kidney cells) [ 23 ]. Smaller particles caused notable toxicity on each cell line, after the exposure time of 24 h, in contrast to the larger particles, which demonstrated no cytotoxic impact [ 23 ]. A comparable outcome has been published to verify the toxic characteristic of mesoporous silica. In this in vitro study, the researchers investigated the effect of MSNs with an average size of 7 nm on cell viability at three different concentrations. After 72 h of exposure, only the highest concentration (62.5 µg/mL) caused a substantial decrease in cell viability of human lung fibroblast cells. This toxicity occurred in a time- and dose-dependent manner [ 32 ]. In an in vivo mouse model, MacCuaig et al. presented coating-dependent impacts after repeated intravenous administration of MSNs. Chitosan-coated MSNs induced minor organ changes and were the most biocompatible. Uncoated and especially PEG-coated MSNs (especially 2K PEG) moderately augmented pre-existing vascular or organ lesions, implying that PEGylation has the potential to augment chronic risks, while chitosan enables safer long-term use [ 34 ]. An in vitro study of Barguilla et al. exposed epithelial lung cells to bare, PEG-functionalized, or galacto-oligosaccharide-functionalized MSNs for eight weeks. There was no reported long-term DNA damage, but malignant-like alterations like anchorage-independent growth, boosted migration/invasion, and secretome-facilitated tumor promotion were triggered by PEG- and GAL-functionalized MSNs. Naked MSNs did not cause such alterations and were determined to be safer [ 35 ]. Coating, on the whole, exerts a significant impact on the safety of MSNs. Uncoated MSNs are relatively innocuous; the most biocompatible coatings were achieved with chitosan, but PEG and carbohydrate functionalization can be dangerous in the long run, from vascular toxicity in vivo to tumor-promoting activity in vitro [ 34, 35 ].

What drives silica raw material prices?

PPG Hi-Sil 34. MacCuaig W.M., Samykutty A., Foote J., Luo W., Filatenkov A., Li M., Houchen C., Grizzle W.E., McNally L.R. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics. 2022;14:969. doi: 10.3390/pharmaceutics14050969. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]

Cite this article: Silica Raw Materials News. "Silica COA: What a Certificate of Analysis Should Include and How to Verify It ." Published 2026-11-20 01:15:34. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.